精构生物完成数千万A轮融资，董事长王志敏控股55%

Group 1 - The core point of the article is that Hangzhou Jingou Biotechnology Co., Ltd. has completed a multi-million A round financing led by Jinding Capital, with participation from several other investment institutions [1] - The financing will primarily be used for research and development investments and the construction of production capacity, aiming to accelerate the large-scale production of high-value-added nutritional health and feed additive products [1] - Jingou Biotechnology, established in 2023, focuses on synthetic biology technology applications in essential areas such as human nutrition and feed additives, with the goal of creating a leading domestic and internationally competitive green biotechnology manufacturing platform [1] Group 2 - The actual controller of Jingou Biotechnology is Wang Zhimin, who holds a total of 55.24% of the shares and serves as the chairman and general manager of the company [3]